Annika Erbacher
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease.
Journal: Stem cells and development
Published: January 15, 2021
Deoxyribonuclease 1-Mediated Clearance of Circulating Chromatin Prevents From Immune Cell Activation and Pro-inflammatory Cytokine Production, a Phenomenon Amplified by Low Trap1 Activity: Consequences for Systemic Lupus Erythematosus.
Journal: Frontiers in immunology
Published: October 02, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or Chemotherapy.
Journal: Stem cells and development
Published: April 17, 2020
Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration.
Journal: International journal of molecular sciences
Published: June 22, 2018
Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγcnull Mice.
Journal: PloS one
Published: October 23, 2015
Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation.
Journal: European cells & materials
Published: January 02, 2015
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.
Journal: BMC cancer
Published: August 25, 2014
Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation.
Journal: Annals of hematology
Published: August 22, 2014
Phagocytic activity of monocytes, their subpopulations and granulocytes during post-transplant adverse events after hematopoietic stem cell transplantation.
Journal: Immunobiology
Published: June 13, 2014
Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation.
Journal: Annals of hematology
Published: June 02, 2014
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation.
Journal: BMC infectious diseases
Published: January 16, 2012
Last Updated: 09/26/2026